Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 10.6b

Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008

Recipients with Intestine Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
Tac Tac+ MMF Tac+ Aza Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 535 127 4 71 23 760
% of All Regimens 70.4% 16.7% 0.5% 9.3% 3.0% 100.0%
Induction Drug 0.2% 2.4% 0.0% 1.4% 17.4% 1.2%
Atgam/NRATG/NRATS
OKT3 3.6% 40.9% 0.0% 8.5% 73.9% 12.4%
Thymoglobulin 10.1% 60.6% 0.0% 26.8% 187.0% 25.4%
Zenapax 10.1% 19.7% 0.0% 8.5% 87.0% 13.8%
Simulect 2.1% 0.8% 0.0% 0.0% 17.4% 2.1%
Campath 25.2% 1.6% 25.0% 5.6% 82.6% 21.2%
No Induction Drugs Recorded 52.5% 16.5% 75.0% 57.7% 56.5% 47.2%


Source: OPTN/SRTR Data as of May 4, 2009.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.



PDF FormatRequires Adobe Acrobat Reader